Normal tissue tolerance to intraoperative radiotherapy

Autor: Hoekstra, HJ, Heijmans, HJ, Cromheecke, M, Szabo, BG

Publikováno v: European Journal of Surgical Oncology, 26, S5-S9. ELSEVIER SCI LTD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::04171f26bba606ddd85d109bd1aae943
https://research.rug.nl/en/publications/109bea91-aab1-429e-aef5-c836d719e082

IS ADJUVANT INTRA-OPERATIVE RADIOTHERAPY (IORT) FOR RESECTABLE AND UNRESECTABLE PANCREATIC-CARCINOMA WORTHWHILE

Autor: HEIJMANS, HJ, HOEKSTRA, HJ, MEHTA, DM

Publikováno v: HEPATO-GASTROENTEROLOGY, 36(6), 474-477. H G E UPDATE MEDICAL PUBLISHING S A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::a45c2fbc14cd1fb9770599145287237f
https://research.rug.nl/en/publications/9468412e-ca5d-4cfa-a3e9-17444975c373

Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.

Autor: Simons JM; Department of Radiotherapy, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Department of Surgical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.; Department of Surgical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, the Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands., van Nijnatten TJA; GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, the Netherlands., van der Pol CC; Department of Surgical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Surgical Oncology, Alrijne Hospital, Leiderdorp, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Jager A; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., van Klaveren D; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands., Kam BLR; Department of Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Nuclear Medicine, Diakonessenhuis, Utrecht, the Netherlands., Lobbes MBI; GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, the Netherlands.; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., de Boer M; GROW-School for Oncology and Reproduction, Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands., Verhoef C; Department of Surgical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Sars PRA; Department of Surgical Oncology, Bravis Hospital, Roosendaal, the Netherlands., Heijmans HJ; Department of Surgical Oncology, Hospital Group Twente, Breast Clinic Oost-Nederland, Hengelo, the Netherlands., van Haaren ERM; Department of Surgical Oncology, Zuyderland Medical Center, Sittard, the Netherlands., Vles WJ; Department of Surgical Oncology, Ikazia Hospital, Rotterdam, the Netherlands., Contant CME; Department of Surgical Oncology, Maasstad Hospital, Rotterdam, the Netherlands., Menke-Pluijmers MBE; Department of Surgical Oncology, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Smit LHM; Department of Surgical Oncology, Treant Zorggroep Hospital, Hoogeveen, the Netherlands., Kelder W; Department of Surgical Oncology, Martini Hospital, Groningen, the Netherlands., Boskamp M; Department of Surgical Oncology, Wilhelmina Hospital, Assen, the Netherlands., Koppert LB; Department of Surgical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Luiten EJT; Department of Surgical Oncology, Amphia Hospital, Breda, the Netherlands.; Tawam Breast Care Center, Tawam Hospital, Al Ain, Abu Dhabi Emirate, United Arab Emirates.; Department of Surgery College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi Emirate, United Arab Emirates., Smidt ML; GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.; Deparment of Surgical Oncology, Maastricht University Medical Center+, Maastricht, the Netherlands.

Publikováno v: JAMA surgery [JAMA Surg] 2022 Nov 01; Vol. 157 (11), pp. 991-999.

Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis.

Autor: Draeger T; Tumor Center Regensburg/University of Regensburg, Institute for Quality Control and Health Services Research, Regensburg, Germany.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Voelkel V; Tumor Center Regensburg/University of Regensburg, Institute for Quality Control and Health Services Research, Regensburg, Germany.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Schreuder K; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Veltman J; Department of Radiology, Ziekenhuisgroep Twente, Almelo, The Netherlands., Dassen A; Department of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands., Strobbe L; Department of Surgery, Canisius Hospital, Nijmegen, The Netherlands., Heijmans HJ; Department of Surgery, Ziekenhuisgroep Twente, Hengelo, The Netherlands., Koelemij R; Department of Surgery, Antonius Ziekenhuis, Nieuwegein, The Netherlands., Groothuis-Oudshoorn CGM; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Siesling S; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.

Publikováno v: The oncologist [Oncologist] 2022 Oct 01; Vol. 27 (10), pp. e766-e773.

The prognostic value of tumour-stroma ratio in triple-negative breast cancer.

Autor: Moorman AM; Department of Surgery, Hospital Group Twente, P.O. Box 7600, 7600 SZ Almelo, The Netherlands. y.moorman@zgt.nl, Vink R, Heijmans HJ, van der Palen J, Kouwenhoven EA

Publikováno v: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2012 Apr; Vol. 38 (4), pp. 307-13. Date of Electronic Publication: 2012 Jan 20.